How to and should we target EBV in MS?

Area of Science:

• Neuroimmunology
• Infectious Disease Epidemiology

Background:

• The precise cause of multiple sclerosis (MS) remains elusive, though it involves genetic, environmental, and behavioral factors.
• A significant body of research suggests a link between Epstein-Barr virus (EBV) infection and the development of MS.

Purpose of the Study:

• To review current evidence on Epstein-Barr virus (EBV) as a potential trigger for multiple sclerosis (MS) onset.
• To explore EBV's interaction with genetic predispositions and other infections in MS pathogenesis.
• To examine EBV's role in MS disease progression and the impact of disease-modifying therapies (DMTs).

Main Methods:

• Narrative review of recent epidemiological and molecular findings.
• Exploration of EBV's interaction with host genetics and co-infections.
• Analysis of EBV's influence on MS progression and treatment responses.

Main Results:

• Strong epidemiological data indicate EBV may be the initiating event for MS in some individuals.
• Variability in susceptibility to EBV-induced MS is influenced by environmental factors.
• Current DMTs' effects on EBV-related mechanisms and potential EBV-specific therapies are discussed.

Conclusions:

• EBV is increasingly recognized as a critical factor in MS etiology for certain populations.
• Future research should identify EBV-specific risk factors and phenotypes.
• EBV-targeted strategies, including vaccination, may offer future therapeutic avenues for MS.